Finding a Better Way:

Size: px
Start display at page:

Download "Finding a Better Way:"

Transcription

1 Finding a Better Way: Genomic Distinctiveness Kyle B. Brothers Genomics and Ethics in Research and Medical Decision-Making Cincinnati, OH March 13, 2015

2 Debates over genomic exceptionalism Overview Clinical analogies Genomic Distinctiveness

3 Genomic Exceptionalism

4 Definitions -ome = noun suffix indicating all of the specified constituents of a cell, considered collectively or in total -omic = adjective suffix with same meaning

5 Genomic Exceptionalism Large number of findings generated simultaneously High likelihood of secondary finding

6 Genomic Exceptionalism Results may need filtering due to: Genomics Overwhelming number of secondary findings Genetics Right not to know Right to an open future

7 Debate Over ACMG Recommendations

8 ACMG Recommendations [W]e felt that clinicians and laboratory personnel have a fiduciary duty to prevent harm by warning patients and their families about certain incidental findings and that this principle supersedes concerns about autonomy, just as it does in the reporting of incidental findings elsewhere in medical practice.

9 Critique of Recommendations Rejecting the need for the patient s informed consent to look for mutations in a predetermined list of 57 genes is a profound departure from prevailing law and norms.

10 Response to Critique To date, the traditions of genetic testing and reporting have exceptionalized all genetic risk information as potentially dangerous to the wellbeing of patients. This tradition, in the era of genome sequencing, must be reconsidered.

11 Clinical Analogies

12 Imaging

13 Imaging CT and MRI capture whole part of the body High likelihood of incidental findings Confirmation potentially risky Genomics WGS captures whole genome High likelihood of secondary findings Confirmation potentially risky

14 Imaging Images display incidental findings by default Filtering requires sophisticated image processing Incidental Genomics Secondary findings are hidden by default Filtering can be achieved by narrowing analysis Secondary

15 Imaging Incidental findings infrequent Narrow scope of possible findings Genomics Almost every patient has secondary findings Potential for secondary findings related to every organ system

16 Imaging vs. Genomics Similar in some ways, different in others These differences could justify differences in practice

17 Newborn Screening

18 NBS New technology (tandem mass spec) provides cheap, easy alternative to multiple existing technologies Also generates large number of results that were not previously obtained Genomics New technology (WGS) provides cheap, easy alternative to multiple existing technologies Also generates large number of results that were not previously obtained

19 NBS Many secondary findings reflect circumstances that are ambiguous not clearcut pathology Confirmatory testing can take time, cause stress Genomics Many secondary findings reflect circumstances that are ambiguous not clearcut pathology Confirmatory testing can take time, cause stress

20 NBS Genomics Results: Reflect current metabolic state Are proximal to clinical signs and symptoms Reflect potential current disease state Results: Reflect genetic composition Are distal from clinical signs and symptoms Typically reflect disease risk

21 NBS Typically performed: In public health setting On healthy patients In infants Genomics Typically performed: In research or clinical setting On patients with clinical indication In adults or children

22 NBS vs. Genomics Similar in some ways, different in others These differences could justify differences in practice

23 Routine Laboratory Panels

24 Typical Laboratory Panels Complete Blood Count: Parameters for variety of cells in the blood Basic Metabolic Panel: 7-8 parameters reflecting fluid and electrolyte status Complete Metabolic Panel: BMP + liver and nutritional parameters

25 Routine Lab Panels Genomics Laboratory devices generate package of findings Not practical to account for individual preferences in components of package Generates unexpected findings that may need to be addressed Secondary findings could be considered part of the package Concerns about practicality of accounting for preferences Can generate unexpected findings that may need to be addressed

26 Routine Lab Panels Genomics Limitations and implications well understood Package is routinely filtered, since laboratory devices can generate more parameters than requested Limitations and implications still poorly understood Concern that failure to analyze for important incidental findings would be unethical

27 Imaging vs. Genomics Similar in some ways, different in others These differences could justify differences in practice

28 Antibiotic Sensitivities

29

30 Antibiotic Sensitivity Reports Genomics Potential to generate large number of findings Total number determined by analytical decisions Potential to generate large number of findings Total number determined by analytical decisions

31 Antibiotic Sensitivity Reports Genomics Filtering is common practice; sensitivities to expensive or restricted antibiotics are suppressed to influence provider practice Concerns about filtering include: Liability for not reporting potentially useful information Paternalistic laboratory practices

32 Antibiotic Sensitivities vs. Genomics Similar in some ways, different in others These differences could justify differences in practice

33 Genomic Distinctiveness

34 Dualist Perspectives Genomics is different, should be treated differently. Genomics is the same, should be treated the same.

35 Exceptionalism in Practice In many debates, both sides accuse the other of exceptionalism Most deny accusations of exceptionalism Not useful for clarifying the issues

36 Distinctiveness Every domains of medicine reflects distinctive traits Each trait is shared with other domains Unique combination of traits defines each domain

37 Genomic Distinctiveness Identify Partial Analogy Claim Practice Should Be The Same

38 Genomic Distinctiveness Identify Relevant Traits Determine Implications of Traits Decide on Practices

39 Thanks! Aaron Goldenberg Nanibaa Garrison Rich Sharp Jen McCormick

Reporting Results and Incidental Findings to Research Participants

Reporting Results and Incidental Findings to Research Participants Reporting Results and Incidental Findings to Research Participants Jeffrey R Botkin, MD, MPH Professor of Pediatrics Chief, Division of Medical Ethics and Humanities Associate Vice President for Research

More information

Jeffrey R Botkin, MD, MPH Professor of Pediatrics Associate Vice President for Research

Jeffrey R Botkin, MD, MPH Professor of Pediatrics Associate Vice President for Research Jeffrey R Botkin, MD, MPH Professor of Pediatrics Associate Vice President for Research Disclosure of Research Results Hot issue at the present time due to whole genome sequencing and imaging in research

More information

GENETIC TESTING A Resource from the American College of Preventive Medicine

GENETIC TESTING A Resource from the American College of Preventive Medicine GENETIC TESTING A Resource from the American College of Preventive Medicine A Time Tool for Clinicians ACPM's Time Tools provide an executive summary of the most up-to-date information on delivering preventive

More information

Question 01 - Health care as a consumer good

Question 01 - Health care as a consumer good Question 01 - Health care as a consumer good The expanding array of medical products and services becoming available as consumer goods outside traditional medical settings raises the stakes on regulating

More information

Implement New Technologies in NBS: Next Generation Sequencing in NBS for Cystic Fibrosis

Implement New Technologies in NBS: Next Generation Sequencing in NBS for Cystic Fibrosis Implement New Technologies in NBS: Next Generation Sequencing in NBS for Cystic Fibrosis Mei Baker, MD, FACMG Co-Director, Newborn Laboratory at WSLH Professor, Department of Pediatrics University of Wisconsin

More information

Genome Sequencing: Applications and Newborn Screening. June 2, 2014

Genome Sequencing: Applications and Newborn Screening. June 2, 2014 Genome Sequencing: Applications and Newborn Screening June 2, 2014 Suzanne Cordovado, PhD Molecular Quality Improvement Program Centers for Disease Control and Prevention National Center for Environmental

More information

Genetically Sequencing Healthy Babies Yielded Surprising Results

Genetically Sequencing Healthy Babies Yielded Surprising Results Genetically Sequencing Healthy Babies Yielded Surprising Results FUTURE FRONTIERS OPINION ESSAY Robert C. Green, MD, MPH January 22, 2019 8 MINUTE READ A newborn and mother in the hospital - first touch.

More information

Genetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health

Genetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health Genetics/Genomics in Public Health Role of Clinical and Biochemical Geneticists in Public Health Premises Human variation is vast Strength of genetic factors are a continuum from low to high Testing technology

More information

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results

More information

Technical Guidance on Development of In Vitro Companion Diagnostics and Corresponding Therapeutic Products

Technical Guidance on Development of In Vitro Companion Diagnostics and Corresponding Therapeutic Products Administrative Notice December 26, 2013 To: Division of Pharmaceutical Affairs, Prefectural Health Department (Bureau) From: Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau Ministry

More information

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience Umberto Filibeck Former Head of AIFA GCP Inspectorate and GCP Promotion Unit UNICRI Consultant for Projects on GCP of CTs in developing

More information

Informed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following

Informed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following Informed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following form carefully and discuss with your ordering physician/genetic counselor before signing consent. 1. The

More information

Clearing a Path for DTC Oversight

Clearing a Path for DTC Oversight Clearing a Path for DTC Oversight DTC Advisory Meeting of the FDA s Molecular and Clinical Genetics Panel Daniel Vorhaus March 8, 2011 Permissions / Disclosures You are free to: Copy, share, adapt, or

More information

Newborn Screening Policy Development in the United States

Newborn Screening Policy Development in the United States Newborn Screening Policy Development in the United States The Changing Scene and The Way Forward in the Genomic Era Association of Public Health Laboratories 2013 Annual Meeting Raleigh, North Carolina

More information

Clinician s Guide to Actionable Genes and Genome Interpretation

Clinician s Guide to Actionable Genes and Genome Interpretation Clinician s Guide to Actionable Genes and Genome Interpretation Brandy Bernard PhD Senior Research Scientist Institute for Systems Biology Seattle, WA Dr. Bernard s research interests are in cancer drug

More information

Applying Simulation Optimization to Improve the Efficiency of Organ Allocation

Applying Simulation Optimization to Improve the Efficiency of Organ Allocation Applying Simulation Optimization to Improve the Efficiency of Organ Allocation Nan Kong, Patricio Rocha Department of Industrial and Management Systems Engineering University of South Florida Outline Motivation

More information

The world contains a vast number of cultures with varying customs and traditions Multinational research is a global enterprise

The world contains a vast number of cultures with varying customs and traditions Multinational research is a global enterprise The problem The world contains a vast number of cultures with varying customs and traditions Multinational research is a global enterprise > Sponsors include industry, industrialized country agencies,

More information

The Next Phase of Newborn Screening : Whole Genome Sequencing?

The Next Phase of Newborn Screening : Whole Genome Sequencing? The Next Phase of Newborn Screening : Whole Genome Sequencing? Prof. B.M. Knoppers Director, Centre of Genomics and Policy McGill University Genetic Alliance, Washington August 20th, 2013 Outline Introduction

More information

6th Form Open Day 15th July 2015

6th Form Open Day 15th July 2015 6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine

More information

BO STO N MEDTECH. More Experience Better Results. Ethics in Clinical Research. Zvi Ladin, Ph.D.

BO STO N MEDTECH. More Experience Better Results. Ethics in Clinical Research. Zvi Ladin, Ph.D. BO STO N MEDTECH A D VI SO RS More Experience Better Results Ethics in Clinical Research Zvi Ladin, Ph.D. Historical Infamy Tuskegee syphilis study (1930s 1972) 399 black men signed with the US PHS for

More information

Clinical trial information leaflet and consent

Clinical trial information leaflet and consent Informed consent 1(7) Clinical trial information leaflet and consent General You must provide sufficient information on the rights of clinical trial subjects, the purpose and nature of the trial, the methodologies

More information

Considerations on Implementing the ACMG IF Recommendations: The Laboratory Perspective

Considerations on Implementing the ACMG IF Recommendations: The Laboratory Perspective Considerations on Implementing the ACMG IF Recommendations: The Laboratory Perspective Elaine Lyon, PhD Medical Director, Molecular Genetics, Associate Professor of Pathology University of Utah School

More information

First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing

First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing Amy L. McGuire, JD, PhD Center for Medical Ethics and Health Policy Baylor College of Medicine DTC Advertising Personal Genome

More information

FDA public meeting on Oversight of Laboratory Developed Tests. Direct to Consumer Genetic Testing. July 20, 2010

FDA public meeting on Oversight of Laboratory Developed Tests. Direct to Consumer Genetic Testing. July 20, 2010 Docket No. FDA-2010-N-0274 July 15, 2010 TO: Katherine Serrano Biomedical Engineer Division of Chemistry and Toxicology Devices Office of In-Vitro Diagnostics/CDRH/FDA 10903 New Hampshire Ave Building

More information

qcarrier Test INFORMATION DOCUMENT

qcarrier Test INFORMATION DOCUMENT qcarrier Test INFORMATION DOCUMENT The qcarrier Test is a laboratory test developed by qgenomics, aimed at studying your genetic material. It is based on a targeted analysis of human genome fragments,

More information

Expansion of Newborn Screening in Wisconsin and Beyond

Expansion of Newborn Screening in Wisconsin and Beyond Expansion of Newborn Screening in Wisconsin and Beyond Charles Brokopp, DrPH Director, Wisconsin State Laboratory of Hygiene Professor, Population Health Sciences School of Medicine and Public Health 2012

More information

Molecular Analysis to Enhance Newborn Screening.. March 1, 2016 Michele Caggana, Sc.D., FACMG February 29, 2016

Molecular Analysis to Enhance Newborn Screening.. March 1, 2016 Michele Caggana, Sc.D., FACMG February 29, 2016 Molecular Analysis to Enhance Newborn Screening.. March 1, 2016 Michele Caggana, Sc.D., FACMG February 29, 2016 March 1, 2016 2.Are You Ready to Jump In?? March 1, 2016 3 Population Based Risk Assessment

More information

EHR Data Analytics Descriptive: Predictive: Prescriptive: Data mining: Personalized medicine: Electronic Health Record (EHR):

EHR Data Analytics Descriptive: Predictive: Prescriptive:  Data mining: Personalized medicine: Electronic Health Record (EHR): EHR Data Analytics 1. Explain the difference between descriptive, predictive and prescriptive analytics. - Descriptive: describes a current or past situation standard types of reporting - Predictive: using

More information

US Policy Developments and Points to Consider for Genomics Research Informed Consent

US Policy Developments and Points to Consider for Genomics Research Informed Consent US Policy Developments and Points to Consider for Genomics Research Informed Consent Marianna J. Bledsoe Independent Research Professional/Consultant Adjunct Assistant Professor George Washington University

More information

Centre for Personalised Medicine in Tübingen - developing tailor-made treatments for patients

Centre for Personalised Medicine in Tübingen - developing tailor-made treatments for patients Powered by Website address: https://www.gesundheitsindustriebw.de/en/article/news/centre-for-personalised-medicine-intuebingen-developing-tailor-made-treatments-for-patients/ Centre for Personalised Medicine

More information

Sema4 CarrierCheck Informed Consent

Sema4 CarrierCheck Informed Consent Sema4 CarrierCheck Informed Consent [last modified July 20, 2017] This informed consent describes the benefits, risks, and limitations of undergoing DNA testing for certain genetic conditions with Sema4

More information

Planning a biomarker-guided trial: points to consider. Dr Andrea Jorgensen Department of Biostatistics University of Liverpool

Planning a biomarker-guided trial: points to consider. Dr Andrea Jorgensen Department of Biostatistics University of Liverpool Planning a biomarker-guided trial: points to consider Dr Andrea Jorgensen Department of Biostatistics University of Liverpool Just one of a team! Work presented today represents significant efforts of

More information

Implementing ACMG guidelines on sequence variant interpretation: software-assisted variant curation and filtering

Implementing ACMG guidelines on sequence variant interpretation: software-assisted variant curation and filtering Cartagenia Bench Lab CASE STUDY Implementing ACMG guidelines on sequence variant interpretation: software-assisted variant curation and filtering Authors: Berivan Baskin 1, PhD, FACMG, FCCMG; Tina Smets

More information

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1 Epidemiologic Research 1 December 12, 2006 Comments on 2006 CIOMS draft Special Ethical Considerations for Epidemiologic Research as proposed supplement to the updated 2002 CIOMS International Ethical

More information

Ethics of disclosing results of genetic testing of donor-derived leukemia to recipient in a. hereditary cancer biology research setting

Ethics of disclosing results of genetic testing of donor-derived leukemia to recipient in a. hereditary cancer biology research setting Ethics of disclosing results of genetic testing of donor-derived leukemia to recipient in a hereditary cancer biology research setting Connie Phung, M.S. 1 1 The University of Chicago, Department of Medicine,

More information

Predicting the Future Through DNA

Predicting the Future Through DNA Predicting the Future Through DNA By Jared Sokol, Junior, Biological Sciences Major Introduction With the completion of the human genome project roughly ten years ago, the medical perception of genetics

More information

So, just exactly when will genetics revolutionise medicine? - Part 1

So, just exactly when will genetics revolutionise medicine? - Part 1 So, just exactly when will genetics revolutionise medicine? - Part 1 PRO F. M A RT IN K E N N E DY D EPA RT M ENT O F PAT H O LO GY & C A R N E Y C E N T R E FO R PH A R M ACO GEN O M IC S U N IVERSIT

More information

Genomics in the NHS. Professor Sue Chief Scientific Officer for England

Genomics in the NHS. Professor Sue Chief Scientific Officer for England Genomics in the NHS Professor Sue Hill @CSOSue Chief Scientific Officer for England Nov 2017 100,000 Genomes Project: overview PRINCIPLES 100,000 genomes from Rare Disease (families) & Cancer (people &

More information

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap

More information

Frequently Asked Questions

Frequently Asked Questions Frequently Asked Questions Genetics Defined What does DNA stand for? DNA stands for deoxyribonucleic acid. This term describes the different chemical building blocks that make up the structure of DNA.

More information

Community Advisory Boards and Animal Research in Precision Medicine

Community Advisory Boards and Animal Research in Precision Medicine Community Advisory Boards and Animal Research in Precision Medicine Richard R. Sharp, Ph.D. Director, Biomedical Ethics Research Program Mayo Clinic ILAR Roundtable October 6, 2017 2017 MFMER slide-1 Overview

More information

The Wonderful World of Informatics

The Wonderful World of Informatics The Wonderful World of Informatics VI Jornadas Universitarias de Sistemas de Informción en Salud 31 de octubre, 1 y 2 de noviembre 2011 W. Ed Hammond, PhD, FACMI, FAIMI, FAIMBE, FHL7 Director, Duke Center

More information

NOTICE. Subject: Stakeholders suggestions/comments on Clinical Trials conductance in India

NOTICE. Subject: Stakeholders suggestions/comments on Clinical Trials conductance in India NOTICE Dated: 28.07.2014 Subject: Stakeholders suggestions/comments on Clinical Trials conductance in India During the briefing on CDSCO, Hon ble Minister of Health & Family Welfare desired that there

More information

Genomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service

Genomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service Genomics for All: From 100,000 genomes to a national NHS Genomic Medicine Service Professor Dame Sue Hill @CSOsue Chief Scientific Officer for England SRO Genomics, NHS England September 2018 Genomics:

More information

Nanthealth Patient Informed Consent

Nanthealth Patient Informed Consent Patient Informed Consent Why am I being asked to give consent? You are being asked to sign this consent form because you want to have a molecular/genomic analysis performed to help your physician understand

More information

The Intersection of Genomics Research and the IDE Regulation

The Intersection of Genomics Research and the IDE Regulation The Intersection of Genomics Research and the IDE Regulation Katherine Donigan, Ph.D. Personalized Medicine Staff FDA/CDRH/OIR October 19, 2017 1 In Vitro Diagnostic (IVD) Regulation Through the 1976 medical

More information

Genetic Resource Centre Roy Romanow Provincial Laboratory

Genetic Resource Centre Roy Romanow Provincial Laboratory Genetic Resource Centre Roy Romanow Provincial Laboratory Frequently Asked Questions (FAQ) Phone: 306.655.6450 Email: GRC@saskhealthauthority.ca General FAQ for the Genetic Resource Centre (GRC) 1. Is

More information

Frumkin, 2e Part 1: Methods and Paradigms. Chapter 6: Genetics and Environmental Health

Frumkin, 2e Part 1: Methods and Paradigms. Chapter 6: Genetics and Environmental Health Frumkin, 2e Part 1: Methods and Paradigms Chapter 6: Genetics and Environmental Health Genetics Genetics, the study of individual genes, has expanded to include genomics, which is the study of all the

More information

SPECIMEN INFORMATION PATIENT INFORMATION REFERRING PROVIDER INFORMATION. Institution: Same as Referring Provider

SPECIMEN INFORMATION PATIENT INFORMATION REFERRING PROVIDER INFORMATION. Institution: Same as Referring Provider The LMM is a satellite facility of Massachusetts General Hospital. CLIA # 22D1005307 Specimen (Refer to page 4 for Specimen and Shipping requirements): SPECIMEN INFORMATION Blood (5-7mL K 2 EDTA/K 3 EDTA)

More information

APPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use.

APPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use. APPLICATION FORM Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use. Form 1 This application form should be completed and submitted

More information

The HL7 Clinical Genomics Work Group

The HL7 Clinical Genomics Work Group HL7 Clinical Genomics Domain Information Model The HL7 Clinical Genomics Work Group Prepared by Amnon Shabo (Shvo), PhD HL7 Clinical Genomics WG Co-chair and Modeling Facilitator Pedigree (family health

More information

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

Short Title: CCI Biobank

Short Title: CCI Biobank Patient Label Stamp or letterhead of the department Patient Information Donation, Storage and Use of Biological Materials and Collection, Processing and Use of Data of the CCI Biobank, Medical Center -

More information

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS THE DOORS ARE OPEN: FEEL FREE TO COME IN CENTOGENE UNLOCKS THE POWER OF GENETIC INSIGHTS TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH GENETIC

More information

A. TRIAL IDENTIFICATION

A. TRIAL IDENTIFICATION PROTOCOL INFORMATION ON A CLINICAL TRIAL ON A MEDICINAL PRODUCT FOR HUMAN USE CONDUCTED IN A THIRD COUNTRY (i.e. a country outside of the EEA) Note: To ensure consistency the numbering of this form is

More information

Genomics and personalised medicine

Genomics and personalised medicine Genomics and personalised medicine Dr Tom Fowler, Deputy Chief Scientist & Director of Public Health WHO Symposium on the Future of Digital Health Systems in the European Region February 2019 About me

More information

From Gene-Targeted Tests to Genome-Wide Data in Cancer Genetics: A Paradigm for the Development of Personalised Genomic Medicine?

From Gene-Targeted Tests to Genome-Wide Data in Cancer Genetics: A Paradigm for the Development of Personalised Genomic Medicine? From Gene-Targeted Tests to Genome-Wide Data in Cancer Genetics: A Paradigm for the Development of Personalised Genomic Medicine? Third workshop Genomic Data: Challenges to the Concept and Practice of

More information

CITI Certificates

CITI Certificates CITI Certificates 2017-2018 Adu.Research.Office@adu.edu Room CC340 Table of Contents Human Subjects Research... 1 Biomedical Research - Basic/Refresher - Basic Course:... 1 Required Courses:... 1 Human

More information

September 8, General Comments:

September 8, General Comments: September 8, 2009 AMP Comments on the draft report from the Agency for Healthcare Research and Quality (AHRQ): AHRQ Draft Report on Quality, Regulation and Clinical Utility of Laboratorydeveloped Tests.

More information

Standard Operating Procedure. Guidelines for Management of Incidental Findings at PERFORM

Standard Operating Procedure. Guidelines for Management of Incidental Findings at PERFORM Standard Operating Procedure Guidelines for Management of Incidental Findings at PERFORM PC-SOP-GA-011-v02 Revision History Version Reason for Revision Date 01 New SOP Oct/22/2012 02 Revised SOP. Minor

More information

Are there technical solutions for ethical dillemas in NBS?

Are there technical solutions for ethical dillemas in NBS? Are there technical solutions for ethical dillemas in NBS? Viktor Kožich Institute of Inherited Metabolic Disorders, First Faculty of Medicine, CUNI, Prague National Coordination Center for Neonatal Screening

More information

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 Submitted resources from physician organization representatives were mapped

More information

Biotechnology. Chapter 20. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for

Biotechnology. Chapter 20. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for Chapter 20 Biotechnology PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright

More information

What is Genetic Engineering?

What is Genetic Engineering? Selective Breeding Selective Breeding is when someone (humans) breed organisms with specific traits in order to produce offspring having those same traits. This is also called artificial selection, the

More information

What does it mean for general practice?

What does it mean for general practice? The New Zealand Laboratory Schedule and Test Guidelines: What does it mean for general practice? 2 November 2013 best tests A new schedule for laboratory testing in New Zealand In October, 2013, a new

More information

INDIVIDUALIZED TREATMENT

INDIVIDUALIZED TREATMENT 1 INDIVIDUALIZED TREATMENT The healthcare system is under pressure: better budgetary compliance, quicker treatment, more equitable patient rights, and higher expectations from patients and relatives. These

More information

Recommendations for returning genomic incidental findings? We need to talk!

Recommendations for returning genomic incidental findings? We need to talk! special article American College of Medical Genetics and Genomics Recommendations for returning genomic incidental findings? We need to talk! Wylie Burke, MD, PhD 1, Armand H. Matheny Antommaria, MD, PhD

More information

Germline Gene Therapy

Germline Gene Therapy Germline Gene Therapy US275 Scientific Ethics John R. Hoffman Arcadia University 1 Germline gene therapy is the placement of new DNA into a fertilized egg. http://genmed.yolasite.com/basics-of-gene-therapy.php

More information

Annex VIIIB Paragraphs to be included in the Informed Consent Form for the collection and use of biological samples in clinical trials

Annex VIIIB Paragraphs to be included in the Informed Consent Form for the collection and use of biological samples in clinical trials DEPARTAMENTO DE MEDICAMENTOS DE USO HUMANO Annex VIIIB Paragraphs to be included in the Informed Consent Form for the collection and use of biological samples in clinical trials Version 20 th December

More information

2018/2019 final draft National Genomic Test Directory FAQ

2018/2019 final draft National Genomic Test Directory FAQ 2018/2019 final draft National Genomic Test Directory FAQ August 2018 1 Contents 1 Introduction... 3 2 About the Test Directory... 3 3 Frequently asked questions... 4 3.1 Where has the Test Directory been

More information

An Integrated Approach to Patient Experience Analytics

An Integrated Approach to Patient Experience Analytics An Integrated Approach to Patient Experience Analytics Director of Value Analytics Johns Hopkins Medicine Email: KLee31@jhmi.edu Vision, Mission, and Values Vision Enhance the value of health care services

More information

Targeted Sequencing in the NBS Laboratory

Targeted Sequencing in the NBS Laboratory Targeted Sequencing in the NBS Laboratory Christopher Greene, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Gene Sequencing in Public Health Newborn Screening February

More information

Policy Number: Title: Abstract Purpose: Policy Detail:

Policy Number: Title: Abstract Purpose: Policy Detail: - 1 - Policy Number: N04202 Title: NHP/NHIC-Medical Policy-Genetic, Genotype and Genomic Testing Abstract Purpose: The purpose of this policy to provide guidance for decisions related to genetic, genotype

More information

Implications for the Future Issues in Ethics. David Castle Department of Philosophy University of Guelph

Implications for the Future Issues in Ethics. David Castle Department of Philosophy University of Guelph Implications for the Future Issues in Ethics David Castle Department of Philosophy University of Guelph dcastle@uoguelph.ca Ouline 1. Bread and butter bioethical issues a) Goals of Nutrigenomics b) Delivery

More information

GMO Technology Conference

GMO Technology Conference GMO Technology Conference The regulation of Clinical Trials on humans involving therapies containing or consisting of genetically modified organisms The Printworks, Dublin Castle 10 th & 11 th October

More information

Chapter 9. Health and Safety CHAPTER SUMMARY

Chapter 9. Health and Safety CHAPTER SUMMARY Chapter 9 Health and Safety CHAPTER SUMMARY This chapter shows that workers have a right to a safe and healthy workplace and that employers have a moral and, in many cases, a legal obligation to secure

More information

June 2013 Clinical Laboratory News: Volume 39, Number 6

June 2013 Clinical Laboratory News: Volume 39, Number 6 June 2013 Clinical Laboratory News: Volume 39, Number 6 Competency Assessment Does the New CLIA Guidance Mean Big Changes? By Bill Malone Laboratory professionals work in one of the most highly regulated

More information

ETHICAL, LEGAL AND SOCIAL ISSUES IN DRUG DEVELOPMENT AND PHARMACOGENOMICS: Report on a Qualitative Study of the Perspectives of Canadian Stakeholders

ETHICAL, LEGAL AND SOCIAL ISSUES IN DRUG DEVELOPMENT AND PHARMACOGENOMICS: Report on a Qualitative Study of the Perspectives of Canadian Stakeholders ETHICAL, LEGAL AND SOCIAL ISSUES IN DRUG DEVELOPMENT AND PHARMACOGENOMICS: Report on a Qualitative Study of the Perspectives of Canadian Stakeholders SHANNON GIBSON University of Toronto Faculty of Law

More information

23andMe Personal Genome Service (PGS) Genetic Health Risk Report Package Insert BRCA1/BRCA2 (Selected Variants)

23andMe Personal Genome Service (PGS) Genetic Health Risk Report Package Insert BRCA1/BRCA2 (Selected Variants) 23andMe Personal Genome Service (PGS) Genetic Health Risk Report Package Insert /BRCA2 (Selected Variants) Table of contents Indications for use Summary and explanation of the test Important considerations

More information

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital

Trend in diagnostic biochip. Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital Trend in diagnostic biochip development Eiichiro Ichiishi, M.D., Ph.D. Department of Internal Medicine International University of Health and Welfare Hospital Handling of the early stage is important for

More information

NHS Research Ethics Approval the process

NHS Research Ethics Approval the process NHS Research Ethics Approval the process Dr Sheila A Simpson 27 May 2008 ETHICS The process of determining what is right and wrong Personal code of conduct based on respect for one's self, others, and

More information

Functional Classification of Medicine

Functional Classification of Medicine Research on Humans Functional Classification of Medicine Medicine and medical intervention can take any of five forms: (1) Therapeutic (curative): seeks to cure a disease or ailment. (2) Palliative: seeks

More information

Patient Handbook on Stem Cell Therapies

Patient Handbook on Stem Cell Therapies Patient Handbook on Stem Cell Therapies WWW.ISSCR.ORG WWW.CLOSERLOOKATSTEMCELLS.ORG Patient Handbook on Stem Cell Therapies Introduction We have all heard about the extraordinary promise that stem cell

More information

School of Allied Medical Sciences. Course Description Guide Associate in Medical Laboratory Sciences. Page 1 of 15

School of Allied Medical Sciences. Course Description Guide Associate in Medical Laboratory Sciences. Page 1 of 15 School of Allied Medical Sciences Course Description Guide Associate in Medical Laboratory Sciences Page 1 of 15 Program Name & Definition: Associate in Medical Laboratory Sciences Laboratory sciences

More information

EFI 2016 DEBATE: WHOLE GENE VERSUS EXONIC SEQUENCING. Dr Katy Latham Stance: Whole gene sequencing should be the norm for HLA typing

EFI 2016 DEBATE: WHOLE GENE VERSUS EXONIC SEQUENCING. Dr Katy Latham Stance: Whole gene sequencing should be the norm for HLA typing EFI 2016 DEBATE: WHOLE GENE VERSUS EXONIC SEQUENCING Dr Katy Latham Stance: Whole gene sequencing should be the norm for HLA typing Why we should be utilising whole gene sequencing Ambiguity generated

More information

Undergraduate Research in the Brzustowicz Laboratory Human Genetics Institute Department of Genetics Rutgers University

Undergraduate Research in the Brzustowicz Laboratory Human Genetics Institute Department of Genetics Rutgers University Undergraduate Research in the Brzustowicz Laboratory Human Genetics Institute Department of Genetics Rutgers University Genetics plays an important role in the development of many of the major psychiatric

More information

Canada's IRIDA platform for genomic epidemiology. Gary Van Domselaar Chief, Bioinformatics National Microbiology Lab Public Health Agency of Canada

Canada's IRIDA platform for genomic epidemiology. Gary Van Domselaar Chief, Bioinformatics National Microbiology Lab Public Health Agency of Canada Canada's IRIDA platform for genomic epidemiology Gary Van Domselaar Chief, Bioinformatics National Microbiology Lab Public Health Agency of Canada Integrated Rapid Infectious Disease Analysis informatics

More information

FDA Regulation of Companion Diagnostics

FDA Regulation of Companion Diagnostics FDA Regulation of Companion Diagnostics Paul Radensky October 11, 2017 Disclosure + Slideset drawn from Part I of presentation made by Janice Hogan, HoganLovells, October 2016 + Updated where appropriate

More information

Performance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen

Performance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen 1 // Performance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen ABSTRACT Here we describe the analytical performance of the newly developed non-invasive prenatal multi-gene

More information

RP1: AN EXAMPLE OF REVERSE GENETICS APPROACH TO DESCRIBE COMMON RECESSIVE DEFECTS

RP1: AN EXAMPLE OF REVERSE GENETICS APPROACH TO DESCRIBE COMMON RECESSIVE DEFECTS RP1: AN EXAMPLE OF REVERSE GENETICS APPROACH TO DESCRIBE COMMON RECESSIVE DEFECTS C. Grohs GABI, INRA, AgroParisTech, Université Paris Saclay 28 / 08 / 2017 Outbreaks of recessive defects as a consequence

More information

Biology 445K Winter 2007 DNA Fingerprinting

Biology 445K Winter 2007 DNA Fingerprinting Biology 445K Winter 2007 DNA Fingerprinting For Friday 3/9 lab: in your lab notebook write out (in bullet style NOT paragraph style) the steps for BOTH the check cell DNA prep and the hair follicle DNA

More information

November 15, 2011 Louis I. Hochheiser, M.D. Chief Medical Leader

November 15, 2011 Louis I. Hochheiser, M.D. Chief Medical Leader Facilitating Development and Utilization of Genome-Based Diagnostic Technologies: Advancing utility and adoption of clinical genomic diagnostics Part II November 15, 2011 Louis I. Hochheiser, M.D. Chief

More information

European Medicines Agency Perspective

European Medicines Agency Perspective European Medicines Agency Perspective WMA Workshop on revision of DoH, 4-6 Dec 2012, Capetown, South Africa. Presented by: Fergus Sweeney, PhD Head of Sector, Compliance and Inspection, European Medicines

More information

Genomic Information Revolution(s)

Genomic Information Revolution(s) Genomic Information Revolution(s) Scott D. Kahn, PhD Chief Information Officer 18 September 2013 2013 Illumina, Inc. All rights reserved. Illumina, IlluminaDx, BaseSpace, BeadArray, BeadXpress, cbot, CSPro,

More information

Emerging biotechnologies: technology, choice and the public good. a guide to the report

Emerging biotechnologies: technology, choice and the public good. a guide to the report Emerging biotechnologies: technology, choice and the public good a guide to the report Contents Introduction 1 What is an emerging biotechnology? 2 The biotechnology wager 3 Biotechnology promises and

More information

Draft agreed by SWP, vswp and GMP/GDP Inspectors WG September Adopted by CVMP for release for consultation 8 November 2016

Draft agreed by SWP, vswp and GMP/GDP Inspectors WG September Adopted by CVMP for release for consultation 8 November 2016 15 December 2016 EMA/CHMP/CVMP/SWP/463311/2016 Committee for Medicinal Products for Veterinary Use (CVMP) Committee for Medicinal Products for Human Use (CHMP) Questions and answers on implementation of

More information

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome. Glossary of Terms Genetics is a term that refers to the study of genes and their role in inheritance the way certain traits are passed down from one generation to another. Genomics is the study of all

More information

Implementing ACMG guidelines on sequence variant interpretation: software-assisted variant curation and filtering

Implementing ACMG guidelines on sequence variant interpretation: software-assisted variant curation and filtering Cartagenia Bench Lab Case Study Implementing ACMG guidelines on sequence variant interpretation: software-assisted variant curation and filtering At a Glance In this case study, you will learn: How Uppsala

More information

Chapter 5 Learning Objectives

Chapter 5 Learning Objectives Schedule and Announcements Go over Exam 1 Look at Elodea (plant cells) Start Chapter 5 Quiz Thursday over lab material Science Café 2 Friday Don t forget- research plan for project is due Friday September

More information